Combination of the Deacetylase Inhibitor Panobinostat and the Multi-Kinase Inhibitor Sorafenib for the Treatment of Metastatic Hepatocellular Carcinoma - Review of the Underlying M...

Por Gahr, Susanne, Wissniowski, Till, Zopf, Steffen, Strobel, Deike, Pustowka, Anette, Ocker, Matthias
Publicado em 2012

Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy

Por Ocker, Matthias, Ganslmayer, Marion, Zopf, Steffen, Gahr, Susanne, Janson, Christopher, Hahn, Eckhart G., Herold, Christoph
Publicado no World J Gastroenterol (2005)

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

Por Zopf Steffen, Ocker Matthias, Neureiter Daniel, Alinger Beate, Gahr Susanne, Neurath Markus F, Di Fazio Pietro
Publicado em 2012-09-01

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

Por Zopf, Steffen, Ocker, Matthias, Neureiter, Daniel, Alinger, Beate, Gahr, Susanne, Neurath, Markus F, Di Fazio, Pietro
Publicado em 2012

The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis

Por Di Fazio, Pietro, Schneider-Stock, Regine, Neureiter, Daniel, Okamoto, Kinya, Wissniowski, Till, Gahr, Susanne, Quint, Karl, Meissnitzer, Matthias, Alinger, Beate, Montalbano, Roberta, Sass, Gabriele, Hohenstein, Bernd, Hahn, Eckhart G., Ocker, Matthias
Publicado no Cell Oncol (2010)